About this trial
The aim of this study is to demonstrate the feasibility and reliability of using virtual reality-based BeCureTM in the assessment of upper extremity motor functions in stroke patients.It is necessary to define the appropriate patient profile for the evaluation of upper extremity motor functions in stroke patients with virtual reality method. We aimed to examine the effects of demographic characteristics, accompanying cognitive disorders and upper extremity motor disorders that may affect the evaluation and response to treatment on virtual reality applications. Therefore, BeCure TM virtual reality system can be feasibly used in the evaluation and rehabilitation of stroke patients.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients diagnosed with stroke according to the World Health Organization with an age range of 18-80 years
Patients with subacute to chronic stroke
Patients who can understand commands
Patients with sitting balance
Disqualifiers
History of seizures or epilepsy (except childhood febrile seizures),
Arthritis or pain in the affected upper limb that limits repetitive exercise,
Severe aphasia, cognitive impairment (premorbid dementia) or psychiatric disorders,
Spasticity in the affected arm is 3 or more compared to MAS,
Trial population
Post-stroke patients consecutively admitted to Ankara University Faculty of Medicine, Department of Physical Medicine and Rehabilitation will be included in the study.
Trial design
Case-control
Cross-sectional
Treatments tested in this trial
Feasibility and reliability of using BeCureTM Virtual Reality in the evaluation of upper extremity motor functions in stroke patients
Diagnostic testThe applicability and reliability of virtual reality systems are important factors to consider. Based on this, this study aimed to investigate the feasibility of using BeCureTM virtual reality in the evaluation of upper extremity functions after stroke.The feasibility of using BeCureTM virtual reality in stroke patients will be determined according to the System Usability Scale (SUS) score.The safety of the use of BeCureTM virtual reality in stroke patients will be assessed with a patient feedback questionnaire. The relationship between the use of BeCureTM virtual reality and cognitive functions in stroke patients will be determined by the Montreal Cognitive Assessment Scale and Mini Mental State Examination.It was aimed to examine the effects of demographic characteristics, accompanying cognitive disorders and upper extremity motor disorders that may affect the evaluation and response to treatment on virtual reality applications.
Treatment groups
Trial outcomes
Primary outcomes
The feasibility of using BeCureTM virtual reality in stroke patients will be determined according to the System Usability Scale (SUS) score.
The System Usability Scale (SUS) is a simple, ten-item Likert scale of subjective evaluations of usability. It was developed in 1986 by John Brooke for usability evaluation. In short, it is a standardized questionnaire to measure users' satisfaction with a product or system. At the same time, a score between 0-100 can be obtained with SUS. When calculating the exact score, 1 is subtracted from the given value of items 1, 3, 5, 7 and 9 (odd numbered and positive opinion). The scores for items 2, 4, 6, 8 and 10 (items with negative opinions) are subtracted from 5. The SUS score can then be found by adding them all together and multiplying this sum by 2.5 to complete the 0-100 range. The minimum score is 0 points and the maximum score is 100 points. A higher score indicates better usability.
Secondary outcomes
1- A patient feedback questionnaire on the safety of BeCureTM virtual reality use will be completed.
1. Patient feedback questionnaire will be completed for the reliability of BeCureTM virtual reality use in stroke patients. 2. The relationship between the use of BeCureTM virtual reality and cognitive functions in stroke patients will be determined by the Montreal Cognitive Assessment Scale and Mini Mental State Examination.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.